- 5
- 0
- 约8.17千字
- 约 21页
- 2018-06-06 发布于贵州
- 举报
抗生素英文课件精品Antimicrobial Resistance(AMR)
Dr. Geeta Shakya Director, NPHL, Teku World Health Day 7th April, 2011 Antimicrobial Resistance(AMR) One of the major challenges facing public health in this century a threat to current and future medical advances Bigger problem in developing countries like Nepal Spreading across countries and regions resulting increased cost of treatment increased morbidity and mortality Constraints Often, the use of practical guidelines in the management of key infectious diseases in the developing world is hampered by the lack of reliable antimicrobial surveillance data When minimum requirements of AMR surveillance are met, data obtained from Antimicrobial Susceptibility Testing (AST) are of great importance to provide more effective therapy and minimize treatment failure Resistance is accelerated through inappropriate use of antimicrobials Standard treatment guidelines not provided to physicians or provided but not adhered to Drugs available without prescription Accessible but poor quality Inadequate monitoring Irrational self-administration or prescription Antimicrobial resistance What is antimicrobial resistance ? Unresponsiveness to antimicrobial agents in standard doses A natural biological unstoppable phenomenon May be inherent resistance or acquired resistance Resistance is generally slow to reverse or irreversible Resistance develops through: ?gene action (mutation) ?plasmid exchange between bacteria of the same species. All antimicrobial agents have the potential to select drug-resistant subpopulations of microorganisms Importance of AMR Surveillance Antibiotics are valuable and most utilized therapeutic agents for life saving Emergence of multi-drug resistance has limited therapeutic options Need for the development of newer drugs frequently which is very costly In vitro Antibiotic susceptibility testing (AST) is the mainstay for monitoring therapy and detecting resistance Reporting of AMR data is necessary for: selection of em
您可能关注的文档
- 抗生素PPT课件(英文精品)Infectious Diseases Resistant .ppt
- 抗生素PPT课件(英文精品)Lactam .ppt
- 抗生素PPT课件(英文精品)Lives Saved Tool (LIST) What is .ppt
- 抗生素PPT课件(英文精品)Information on Staphlococcus aureus and Resistant Staphlococcus aureus (MRSA).ppt
- 抗生素PPT课件(英文精品)Chemotherapy Out of Hours Triage Neutopenic .ppt
- 抗生素PPT课件(英文精品)Combating Communicable Diseases in Northern .ppt
- 抗生素PPT课件(英文精品)Food additives .ppt
- 抗生素PPT课件(英文精品)Meningitis Lumbar .ppt
- 抗生素PPT课件(英文精品)Mathematical Modelling and Challenges in the Development of Drug .ppt
- 抗生素PPT课件(英文精品)Meningitis Commonly Asked .ppt
- 抗生素英文课件精品Appropriate Antibiotics use in CAP and HCAP at Sisters Hospital in .ppt
- 抗生素英文课件精品Appropriate Use of .ppt
- 抗生素英文课件精品AntibioticsProtein Synthesis Nucleic Acid Synthesis and .ppt
- 抗生素英文课件精品Antibiotics and .ppt
- 抗生素英文课件精品Drugsand the Elderly Practical .ppt
- 抗生素英文课件精品ANTIBIOTICS(39p).ppt
- 抗生素英文课件精品Bacteria Subsisting on .ppt
- 抗生素经验治疗的选择(英文PPT)Selectionof empiric antibiotic .ppt
- 抗生素英文课件精品Defending the body from .ppt
- 抗生素英文课件精品ChoosingAntibiotics Before and After the Culture .ppt
最近下载
- 中诚信国际-2025年城投行业运行回顾与2026年展望-“退平台”倒计时下的城投风险再审视.pdf VIP
- 15-《渗透检测》第6-9章-张彦新概要.ppt
- cobas® cobas 系统 6800 8800 Systems p 680 instrument 说明书用户手册.pdf
- 项目总工手册(2023版).docx
- 北师大版三年级下册数学全册教学设计(配2026年春改版教材).docx
- 石化公司物资采购管理办法.pptx VIP
- DB31T 1661-2025 公共区域电子屏播控安全管理要求.docx VIP
- ANSI ESD S20.20-2021(完整中文版本).docx VIP
- 梅江会战扬威名.doc VIP
- 开工第一课(2026)课件.ppt
原创力文档

文档评论(0)